These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2494313)

  • 1. Tissue plasminogen activator administration and nursing considerations.
    Greco A
    J Intraven Nurs; 1989; 12(1):20-4. PubMed ID: 2494313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
    Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
    J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.
    Evrengul H; Celek T; Tanriverdi H; Kaftan A; Dursunoglu D; Kilic M
    Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Verh K Acad Geneeskd Belg; 1989; 51(3):191-228; discussion 229. PubMed ID: 2686261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction.
    Gurbel PA; Anderson RD; MacCord CS; Scott H; Serebruany V; Herzog WR
    Coron Artery Dis; 1994 Nov; 5(11):929-36. PubMed ID: 7719525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombolytic therapy in acute myocardial infarct].
    von Essen R
    Z Gesamte Inn Med; 1987 Sep; 42(17):486-91. PubMed ID: 3120430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in reperfusion therapy for acute myocardial infarction.
    Morgan CD
    Can J Cardiol; 1995 May; 11(5):435-40. PubMed ID: 7750041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic therapy: a review of the literature on streptokinase and tissue plasminogen activator with implications for practice.
    Brewer-Senerchia C
    Crit Care Nurs Clin North Am; 1989 Jun; 1(2):359-71. PubMed ID: 2510771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of new thrombolytic substances].
    Zeymer U; Neuhaus KL
    Herz; 1994 Dec; 19(6):314-25. PubMed ID: 7843688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anaphylactoid reaction during administration of tissue plasminogen activator (t-PA)].
    Cannas S; De Leo A; Marzari A
    G Ital Cardiol; 1997 Mar; 27(3):278-80. PubMed ID: 9244730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional and systemic thrombolytic therapy in acute myocardial infarction.
    Hastillo A; Cowley MJ
    Cardiovasc Clin; 1984; 14(3):235-45. PubMed ID: 6722853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator.
    Glazier JJ; Crowley J; Cremin D; Coll T; Daly K
    Ir Med J; 1989 Sep; 82(3):111-4. PubMed ID: 2513287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
    Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
    Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous transluminal coronary angioplasty during acute myocardial infarction.
    Remetz MS; Cleman MW
    Cardiol Clin; 1988 Feb; 6(1):139-52. PubMed ID: 2971441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous transluminal coronary angioplasty for acute myocardial infarction.
    Rothbaum DA; Hodes ZI; Linnemeier TJ; Landin RJ; Ball MW
    Cardiol Clin; 1989 Nov; 7(4):837-51. PubMed ID: 2688885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of combination therapy of hybrid thrombolysis followed by back-up percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction].
    Mukawa H; Sone T; Tsuboi H; Kondo J; Kosokabe T; Uesugi M; Imai H
    J Cardiol; 2001 Apr; 37(4):181-9. PubMed ID: 11337927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombolysis in acute myocardial infarct: prerequisites, current experiences and remaining problems].
    Rapold HJ
    Schweiz Med Wochenschr; 1986 Aug; 116(33):1074-87. PubMed ID: 3094141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.